Journal of Evidence-Based Medicine

Cover image for Vol. 10 Issue 3

Edited By: Prof. You-Ping Li (Chinese Cochrane Center, China); Prof. Mike Clarke (All Ireland Hub for Trials Methodology Research, UK)

Online ISSN: 1756-5391



Author Guidelines


AIMS AND SCOPE

Journal of Evidence-Based Medicine (JEBM) is the official English language journal of the Chinese Cochrane Centre. The journal aims to present the newest research results and promote the international understanding and development of evidence-based decision-making, research, practice, and education. Papers in any of the following fields will be considered: editorial, commentary, systematic review, clinical trial and register, methodology, policy-making and management, drug safety, education, patient safety, and knowledge translation. The journal encourages submissions from interdisciplinary studies.

EDITORIAL REVIEW AND ACCEPTANCE

The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are double-blind peer reviewed by two anonymous reviewers and the Editors. Final acceptance or rejection rests with the Editors, who reserve the right to refuse any material for publication.

Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editors and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader.

JEBM employs a plagiarism detection system. By submitting your manuscript to this journal, you accept that your manuscript may be screened for plagiarism against previously published works.

SUBMISSION OF MANUSCRIPTS

All articles submitted to the journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.

To submit your article, please log on to JEBM's online submission and peer-review system at http://mc.manuscriptcentral.com/journalebm.

Covering letter

Papers are accepted for publication in the journal on the understanding that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter.

The covering letter must also contain an acknowledgement that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified.

Authors must declare any financial support or relationships that may pose conflict of interest by disclosing at the time of submission any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision but, if the article is accepted for publication, the Editor will usually discuss with the authors the manner in which such information is to be communicated to the reader.

If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.

ETHICAL CONSIDERATIONS

Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Brazil in 2013), available at http://www.wma.net/en/30publications/10policies/b3/17c.pdf .

JEBM retains the right to reject any manuscript on the basis of unethical conduct of either human or animal studies.

All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). All clinical trials must be registered in the authorized registers of WHO International Clinical Trial Register Platform, and the registration number must be presented.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

ONLINEOPEN

JEBM accepts article for Open Access publication.

OnlineOpen is available to authors of primary research articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons licence. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access.

Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

For the full list of terms and conditions of using OnlineOpen, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms. Information on the Copyright terms available to authors publishing using OnlineOpen is available in the Copyright section of the JEBM Author Guidelines below.

COPYRIGHT, LICENSING and ONLINE OPEN

Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.

FAQs about the terms and conditions of the standard copyright transfer agreements (CTA) in place for the journal, including terms regarding archiving of the accepted version of the paper, are available at: CTA Terms and Conditions FAQs

OnlineOpen – ‘Gold road’ Open Access. OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons licence. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access, known as ‘gold road’ open access.

OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND).

For more information about the OnlineOpen license terms and conditions click here.

PREPARING YOUR PAPER

English Language Editing Service

Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. Visit http://wileyeditingservices.com/en to learn about the options. All services are paid for and arranged by the author. Please note using the Wiley English Language Editing Service does not guarantee that your paper will be accepted by this journal.

Optimising Your Article for Search Engines

Many students and researchers looking for information online will use search engines such as Google, Yahoo or similar. By optimising your article for search engines, you will increase the chance of someone finding it. This in turn will make it more likely to be viewed and/or cited in another work. We have compiled these guidelines to enable you to maximise the web-friendliness of the most public part of your article.

STYLE OF THE MANUSCRIPT

Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org/. It is strongly recommended that authors read and refer to previous issues of the journal for guidance on style.

It is strongly recommended that the reports of clinical trials follow the CONSORT Statement and its extensions which are available at http://www.consort-statement.org/consort-statement/overview0/, as well as similar publication practices, and the reports of meta-analyses and systematic reviews comply with the PRISMA(formerly QUORUM) Statement, which is available at http://www.prisma-statement.org/. All acupuncture treatment should be described according to the current STRICTA recommendations at http://www.stricta.info/.

The criteria should be referenced as: Revised Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement. MacPherson H, Altman DG, Hammerschlag R, et al. Acupunct Med 2010;28:83-93.

Spelling. The journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary.

Units. All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.

Abbreviations. Abbreviations should be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter, use the abbreviation only.

Trade names. Chemical substances should be referred to by the generic name only. Trade names should not used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

Dates. Date format is 00 Month 0000; for example, 15 September 2003.

PARTS OF THE MANUSCRIPT

The length of an article (including references, endnotes, tables and appendices) should not exceed 6000 words.

Manuscripts should be presented in the following order: (i) title page; (ii) abstract and key words; (iii) text; (iv) acknowledgments; (v) references; (vi) endnotes; (vii) appendices; (viii) figure legends; (ix) tables (each table complete with title and footnotes); and (x) figures. Footnotes to the text are not allowed and any such material should be incorporated as endnotes.

Title page. As articles are double-blind reviewed, material that might identify authorship of the paper should be placed on a cover sheet; this will be detached before the paper is sent to referees.

The title page should contain: (i) the title of the paper; (ii) the full names of the authors; (iii) the addresses of the institutions at which the work was carried out; and (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.

Title. The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 40 characters) should also be provided.

Abstract. All articles except commentary or editorial must have a structured abstract that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Aim, Methods, Results, Conclusions. The abstract should not contain abbreviations or references.

Key words. Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.

Text. Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion.

Acknowledgements. The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not appropriate.

References.

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. Sample references follow:

Journal article

1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum J Comp Neurol 1998;390:537–551.

Book

1.Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Please note that journal title abbreviations should conform to the practices of Chemical Abstracts

For more information about AMA reference style - AMA Manual of Style

Endnotes. Endnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep endnotes brief: they should contain only short comments tangential to the main argument of the paper and should not include references.

Tables. Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Use table footnotes to define abbreviations, acronyms and to show other explanatory notes. Use superscript lower case letters to define footnotes in table, but *, **, *** should be reserved for P values. Statistical measures such as SD or SEM should be identified in the headings.

Figures. All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. If supplied electronically, figures must be supplied as high resolution (at least 300 dpi) files, saved as .eps or .tif. Do not embed figures in the word document – they must be supplied in separate files. More information about digital graphics standards can be found at http://authorservices.wiley.com/bauthor/illustration.asp.

Magnifications should be indicated using a scale bar on the illustration.

Figure legends. Type figure legends on a separate page. Legends should be concise but comprehensive: the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Equations. Equations should be numbered sequentially with Arabic numerals; these should be ranged right in parentheses. All variables should appear in italics. Use the simplest possible form for all mathematical symbols.

Supporting Information. Supporting Information can be a useful way for an author to include important but ancillary information with the online version of an article. Examples of Supporting Information include additional tables, data sets, figures, movie files, audio clips, 3D structure, and other related nonessential multimedia files. Supporting Information should be cited within the article text, and a descriptive legend should be included. It is published as supplied by the author, and a proof is not made available prior to publication; for these reasons, authors should provide any Supporting Information in the desired final format. For further information on recommended file types and requirements for submission, please visit: http://authorservices.wiley.com/bauthor/suppinfo.asp

Associate your ScholarOne account with your ORCID iD
ORCID iD is a unique and persistent identifier that distinguishes you from every other researcher and connects you and your research activities. We encourage you to register for an ORCID iD and then associate it with your ScholarOne account. Click here to find out how.

POST-ACCEPTANCE

Tracking your paper from acceptance to publication

Online production tracking is available for your article through Wiley’s Author Services. Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://www.authorservices.wiley.com/bauthor/eachecklist.asp for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.  

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in an issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After issue publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.

Proofs

It is essential that corresponding authors supply an email address to which correspondence can be emailed while their article is in production.

The corresponding author will receive an e-mail alert containing a link to a website where the proof can be downloaded as Portable Document Format (PDF) typeset page proof. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the Adobe website. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated; otherwise, it may be signed off by the Editor or held over to the next issue. Further information will be sent with the proof.

Offprints

Free access to the final PDF offprint of your article will be available via Author Services only. Additional paper offprints may be ordered online. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com/cos. If you have queries about offprints please e-mail: offprint@cosprinters.com. Single issues of the journal can be purchased from our customer services department.

EDITORIAL CORRESPONDENCE

Editorial Office, Journal of Evidence-Based Medicine
Address: West China Hospital, Sichuan University
No. 37 Wai Nan Guo Xue Xiang
Chengdu, Sichuan 610041, China
Tel: 86-028-8542-2052
Fax: 86-028-8542-2052
Email: jebm_dl@yahoo.com; jebm_zhang@yahoo.com

If you are ready to submit an article, please click on Online Submission.

For online help and tutorials on how to use the online submission site, please click on Help.

Wiley Author Guidelines updated 6 August 2014

SEARCH

SEARCH BY CITATION